Catalyst Healthcare Consulting, Inc. President Nancy Bradish Myers, JD, will lead a breakout session on personalized medicine at the Food and Drug Law Institute’s 53rd annual conference. The panel will address key issues surrounding co-development of therapeutics and diagnostics. Ms. Myers will facilitate the panel, which will feature:

  • Vicki Seyfert-Margolis, PhD, Advisor to FDA Acting Chief Scientist Jesse Goodman
  • Kathy Hudson, PhD, Chief of Staff to NIH Director Francis Collins and former director of the Genetics and Public Policy Center at Johns Hopkins University
  • Bill Pignato, Global Head, Regulatory Affairs, Novartis Molecular Diagnostics
  • Edward Abrahams, PhD, Executive Director, Personalized Medicine Coalition

Further information on the conference is available at